To systematically evaluate the efficacy of steroids in the treatment of vestibular neuritis. Methods: The Cochrane Library, PubMed, Embase, Web of Science, CBM, CNKI, WanFang Data, and VIP databases were electronically searched to collect randomized controlled trials (RCTs) on the efficacy of steroids in the treatment of vestibular neuritis from inception to November 27, 2020. Two reviewers independently screened literature, extracted data, and assessed the risk of bias of included studies. Then, meta-analysis was performed using RevMan5.4 software. Results: A total of 7 RCTs were included, including 294 patients. Results of meta-analysis showed that corticosteroids could promote the improvement of vertigo symptoms 24 hours after treatment (RR=0.29, 95% CI 0.11～0.71, P=0.007). However, there was no statistical significance between the two groups in the Dizziness Handicap Inventory (DHI) score at 1 and 6 months after treatment, the improvement of canal paresis (CP) at 1, 6, and 12 months after treatment, and the mean days of nystagmus disappearance after treatment (P>0.05). Conclusion: The current evidence shows that corticosteroids can promote the recovery of vertigo symptoms in the short term in patients with vestibular neuritis. However, they did not improve semicircular canal function, the recovery of long-term vertigo, and the disappearance of nystagmus.